USCAP

QDx Pathology Services Adopts Proscia’s Software To Improve Speed And Precision

Retrieved on: 
Mardi, mars 19, 2024
Culture, AP, Organization, Digital, Artificial intelligence, News, Marie Cassidy, AI, Software, Laboratory, USCAP, FDA, Medical imaging

Accelerated by a growing base of evidence, laboratories are adopting digital pathology to enhance routine operations, improve decision making, and lay the foundation for unlocking new insights with AI.

Key Points: 
  • Accelerated by a growing base of evidence, laboratories are adopting digital pathology to enhance routine operations, improve decision making, and lay the foundation for unlocking new insights with AI.
  • “At QDx Pathology Services, we are committed to advancing the standard of excellence in pathology,” said Pierre Mouawad, VP of Laboratory Operations.
  • “Proscia’s software makes it easier for our pathologists to do their best work, empowering them to optimize for speed and precision.
  • “It is inspiring to watch QDx Pathology Services take the first steps on its digital pathology journey,” said David West, Proscia’s CEO.

Pramana Achieves Industry-Leading Milestone with Digital Pathology 2.0 Technology

Retrieved on: 
Vendredi, mars 22, 2024
Health, Technology, Health Technology, Artificial Intelligence, Software, Algorithm, Digital, Parasitology, Acquisition, Marie Cassidy, USCAP, Microbiology, Pathology, Data, DICOM, Economics, Medical imaging

Pramana, Inc. , will showcase its suite of transformative solutions enabling Digital Pathology 2.0 at the USCAP annual conference in Baltimore, MD, March 25-28, 2024, at booth #549.

Key Points: 
  • Pramana, Inc. , will showcase its suite of transformative solutions enabling Digital Pathology 2.0 at the USCAP annual conference in Baltimore, MD, March 25-28, 2024, at booth #549.
  • Pramana will highlight its extensive experience and innovative technologies, including the creation of the world’s largest DICOM repository of whole slide images for anatomic pathology, serving some of its flagship customers.
  • Pramana’s cutting-edge whole slide imaging technology achieves first-pass success in scanning nearly any slide suitable for viewing under an optical microscope.
  • For more information on Pramana’s digital pathology offerings, visit booth #549 at USCAP or schedule a meeting .

BostonGene Announces Participation at the United States and Canadian Academy of Pathology 113th Annual Meeting

Retrieved on: 
Jeudi, mars 21, 2024
Software, Research, Professional Services, Pharmaceutical, Oncology, Biometrics, Technology, Artificial Intelligence, Health Technology, Data Analytics, Science, Biotechnology, Health, MD, Baltimore Convention Center, USCAP, Marie Cassidy, Doctor of Philosophy

BostonGene , a leading provider of AI-driven molecular and immune profiling solutions, today announced it will participate in the United States and Canadian Academy of Pathology (USCAP) 113th Annual Meeting, the largest gathering of pathologists in the world.

Key Points: 
  • BostonGene , a leading provider of AI-driven molecular and immune profiling solutions, today announced it will participate in the United States and Canadian Academy of Pathology (USCAP) 113th Annual Meeting, the largest gathering of pathologists in the world.
  • The event will be held from March 23 - 28, 2024, at the Baltimore Convention Center in Baltimore, Maryland.
  • Joe Lennerz, MD, PhD, Chief Scientific Officer at BostonGene, along with members of the BostonGene team, will showcase the power of next-generation multi-platform AI-driven analytics.
  • This innovative approach aims to uncover crucial correlations between tumor genomics, patient immune profiles and treatment efficacy, driving advancements in personalized medicine.

FormaPath announces the novel tissue biopsy grossing platform: nToto™

Retrieved on: 
Mardi, mars 26, 2024
Mayo Clinic, AP, Clinical professor, USCAP, Comparison, Medical imaging

BALTIMORE, March 26, 2024 /PRNewswire/ -- In conjunction with a poster presentation at the United States and Canada Association of Pathologists Annual (USCAP) meeting titled "Current State of Intra-/Interobserver Accuracy and Reproducibility in Tissue Biopsy Grossing and Comparison to an Automated Vision System" – Poster #198, FormaPath is pleased to announce nToto, a new automated tissue visualization system (ATVS) developed in collaboration with Mayo Clinic's Advanced Diagnostics Laboratory.

Key Points: 
  • FormaPath is pleased to announce nToto, a new automated tissue visualization system
    Common grossing metrics have not been captured or examined before, due to a lack of standardization in tissue grossing techniques.
  • The goal of the study was to characterize and quantify inter- and intra-operator variability in routine gross dissection procedures performed by human technicians.
  • Using the results of this study to establish a baseline for comparison, FormaPath was able to confirm the feasibility of an AI-enabled, automated grossing system for standard tissue biopsies.
  • It is intended to support high-throughput AP Labs seeking to streamline the process of preparing tissue specimens for downstream analysis and reporting.

Apollo Showcases Digital Pathology Enhancements at USCAP 2024

Retrieved on: 
Lundi, mars 25, 2024
Electron microscope, Digital pathology, WSI, Digital, Glass, Workflow, USCAP, Forensic pathology, Health, Medical imaging

BALTIMORE, March 25, 2024 /PRNewswire-PRWeb/ -- Apollo, the leading provider of multidisciplinary medical imaging solutions, today unveils the newest enhancements to its multidisciplinary medical imaging platform, arcc®, at this year's United States and Canadian Academy of Pathology (USCAP) annual meeting, March 25-27. These advancements specifically target Digital Pathology workflows, including the integration of z-stacking and expanded support for Whole Slide Imaging (WSI) formats.

Key Points: 
  • Apollo's multidisciplinary medical imaging platform, arcc®, Digital Pathology workflows now include z-stacking and expanded Whole Slide Imaging format support
    BALTIMORE, March 25, 2024 /PRNewswire-PRWeb/ -- Apollo, the leading provider of multidisciplinary medical imaging solutions, today unveils the newest enhancements to its multidisciplinary medical imaging platform, arcc®, at this year's United States and Canadian Academy of Pathology (USCAP) annual meeting, March 25-27.
  • These advancements specifically target Digital Pathology workflows, including the integration of z-stacking and expanded support for Whole Slide Imaging (WSI) formats.
  • With arcc, Pathologists gain access to a comprehensive suite of imaging tools supporting not just WSI, but all sub-specialties and imaging workflows within Pathology, including Gross Imaging, Electron Microscopy, Forensic Pathology, and Cytopathology.
  • Apollo invites attendees to Booth 551 in the USCAP exhibit hall to view the expanded capabilities and Digital Pathology workflow enhancements.

Now Available! Gestalt Announces PathFlow's AI Algorithm Evaluator

Retrieved on: 
Vendredi, mars 22, 2024
Gestalt, Digital pathology, Algorithm, Environment, Health, Marie Cassidy, AI, USCAP, Image analysis, Pathology, Medical device

SPOKANE, Wash., March 22, 2024 /PRNewswire/ -- Gestalt Diagnostics, Inc., a leading provider of (AI)-driven digital pathology solutions, is proud to announce the launch of its leading-edge AI Algorithm Evaluator. This groundbreaking, patent-pending tool empowers pathologists, researchers, and healthcare professionals to assess and compare the performance of AI algorithms with unprecedented precision directly within our award-winning PathFlow® solution. This new feature will be demonstrated during the USCAP 2024 conference in Baltimore this week.

Key Points: 
  • SPOKANE, Wash., March 22, 2024 /PRNewswire/ -- Gestalt Diagnostics, Inc. , a leading provider of (AI)-driven digital pathology solutions, is proud to announce the launch of its leading-edge AI Algorithm Evaluator.
  • Key Features of PathFlow's AI Algorithm Evaluator:
    Side-by-Side Evaluation: The AI Algorithm Evaluator allows users to compare the results of similar algorithms simultaneously.
  • Whether it's accuracy, speed, or other relevant factors, the AI Algorithm Evaluator adapts to your needs.
  • The AI Algorithm Evaluator provides a digital audit trail, documenting the basis on which algorithms are selected.

Ibex Presents New Data from Multiple Studies Showcasing Accuracy of AI in Prostate, Breast and Gastric Cancer Diagnosis

Retrieved on: 
Jeudi, mars 21, 2024
Diagnosis, Champalimaud Foundation, Cone Health Women's Hospital, PPV, Glomus tumor, Adenoma, Overdiagnosis, Incidence, Research, Cancer, Hospital, UPMC, Breast, Marie Cassidy, AI, University, Laboratory, MD, Oncology, Medicine, USCAP, OSU, Dysplasia, Brigham and Women's Hospital, Breast cancer, Ohio State University, Pathology, Champalimaud, Stomach, Artificial intelligence, Annual general meeting, NPV, Medical imaging

BOSTON, March 21, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced excellent results across multiple clinical studies conducted with the University of Pittsburgh Medical Center (UPMC), Brigham and Women's Hospital, Champalimaud Foundation and Ohio State University (OSU). These studies, highlighting the value of Ibex's AI-powered cancer diagnostics solutions in both diagnostic quality and efficiency, will be presented next week at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting.

Key Points: 
  • Brigham and Women's Hospital and Champalimaud Foundation research shows high accuracy levels of Galen Breast in identifying microinvasive carcinoma of the breast.
  • Ohio State University Wexner Medical Center studies show high accuracy for Galen Breast and Galen Gastric in detecting and distinguishing between different types of cancer and in identifying multiple important pathologies.
  • In addition, researchers from OSU Wexner Medical Center will present studies validating Galen Breast's performance in detecting different types of breast cancer.
  • Ibex will be showcasing these findings at the USCAP Annual Meeting taking place in Baltimore, Maryland, between March 23 to 28, at booth number 755.

Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data

Retrieved on: 
Mardi, février 27, 2024
USCAP, Marie Cassidy, Freedom, Traction, Pathology, Metadata, Organization, DICOM, Laboratory, Research, Partnership, Medical imaging

and PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Proscia® , a leading provider of digital and computational pathology solutions, today announced that Pramana, Inc. , an AI-enabled health tech company modernizing the pathology sector, is now a Proscia Ready partner.

Key Points: 
  • and PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Proscia® , a leading provider of digital and computational pathology solutions, today announced that Pramana, Inc. , an AI-enabled health tech company modernizing the pathology sector, is now a Proscia Ready partner.
  • Pramana joins the partner alliance to help life sciences organizations and diagnostic laboratories increasingly leverage enriched, high-quality data, including DICOM images, in their routine research and clinical operations.
  • Proscia Ready was established to help laboratories accelerate the scaled adoption of digital pathology with confidence.
  • To learn more, visit Proscia at booth 200 and Pramana at booth 549 during the upcoming United States and Canadian Academy of Pathology (USCAP) 113th Annual Meeting.

Ibex and PathPresenter Launch Partnership to Accelerate Adoption of AI-powered Digital Pathology

Retrieved on: 
Mercredi, mars 6, 2024
Hospital, USCAP, Ibex, Marie Cassidy, Algorithm, AI, Education, Pathology, Prostate, Entrepreneurship, Annual general meeting, Breast, Third party, HL7, Diagnosis, LIS, Laboratory, Research, Partnership, Medical device

BOSTON and MONTVILLE, N.J., March 6, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and PathPresenter, the global image sharing platform for pathology, today announced a partnership to advance the adoption of AI-powered digital pathology. The two companies will work together to support joint customers via an AI-powered digital pathology solution for laboratories, hospitals and health systems worldwide.

Key Points: 
  • BOSTON and MONTVILLE, N.J., March 6, 2024 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and PathPresenter , the global image sharing platform for pathology, today announced a partnership to advance the adoption of AI-powered digital pathology.
  • The two companies will work together to support joint customers via an AI-powered digital pathology solution for laboratories, hospitals and health systems worldwide.
  • "The digital pathology and AI transformation that Ibex and PathPresenter are championing is modernizing the industry and providing pathologists with AI tools to improve diagnostic accuracy, lab efficiencies and patient outcomes," said Joseph Mossel, CEO and Co-Founder of Ibex Medical Analytics.
  • "We are committed to working with the best partners to advance digital pathology adoption and education, and Ibex is      a clear leader in AI-powered diagnostics," said Dr. Rajendra Singh, founder of PathPresenter.

Mindpeak's AI Comes out on Top in Comparative Study on HER2-low Scoring by Cypath and Institut Gustave Roussy

Retrieved on: 
Vendredi, avril 21, 2023
Biotechnology, Technology, Health, Pharmaceutical, Oncology, Health Technology, Research, Software, Artificial Intelligence, Science, Clinical Trials, Comparison, AIS, HER2, United States and Canadian Academy of Pathology, Marie Cassidy, Cancer, Woman, Prognosis, Multimedia, AstraZeneca, Biomarker, Malignancy, Patient, USCAP, Diagnosis, Mortality, AI, Breast cancer, Disease, Medical imaging, Trastuzumab deruxtecan, Pathology

In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g.

Key Points: 
  • In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g.
  • Furthermore, Mindpeak's AI received the highest scores in a usability evaluation of the AI softwares in all categories.
  • This study was conducted by Cypath-RB together with Institut Gustave Roussy and was presented at the world's leading annual meeting for pathology, the USCAP 2023 (United States and Canadian Academy of Pathology), in New Orleans in mid-March.
  • Recent clinical studies have shown the efficacy treatment (Enhertu, AstraZeneca) in this patient group with significant clinical benefit compared to standard-of-care treatment.